
THE GLOBAL MULTI-OMICS SOLUTION FOR PRECISION ONCOLOGY
Indivumed Therapeutics is a global oncology company, with a focus on bioinformatics and multi-omics-based oncology R&D. By unraveling the complex mechanisms of cancer, we shape a path toward precision oncology.
Through a global network of selected partner clinics, we maintain a unique database of proprietary multi-omics and clinical datasets that reflect the molecular reality of cancer at an unparalleled level.
By mapping the molecular reality of solid cancer and illuminating biological correlates we develop a true picture of oncological diseases. As a trusted development partner for pharmaceutical companies and research institutions, we enhance R&D activities and launch new discovery programs, providing expertise, capabilities, and insight knowledge throughout the whole development process.

COMPANY HISTORY
Change is part of our history. For over 20 years, Indivumed has continued to evolve, forging valuable relationships around the world, and earning an outstanding reputation in the scientific community. We are always looking for new partnerships and methods to support the realization of our vision.
Explore the highlights of our journey:
INDIVUMED THERAPEUTICS MANAGEMENT TEAM
“At Indivumed we are united by a shared responsibility: using our unique expertise and skill sets to work toward individualized cancer diagnosis and treatment for every patient.”
Prof. Dr. med. Hartmut Juhl, Founder and CEO

Prof. Dr. med. Hartmut Juhl
Founder and Chief Executive Officer

Dr. Susanne Arbogast
Chief Medical Officer

Nils Schumacher
Chief Operating Officer

Dr. Stephan Schüller
Chief Financial Officer

Gudrun Niewel
Senior Vice President Finance

Martin Heuseler
Vice President Finance

Dr. Jonathan Woodsmith
Vice President Advanced Analytics & AI

Nina Gabelia, MD, MPH
Vice President Global Clinical Network Operations

Rene Steen
Vice President Information Technology

Dr. Hans Vanhooren
Vice President Business Development

Kristin Maack
Vice President Marketing & Corporate Communications

Dr. Daniel Pohlmann
Senior Director Oncology Analytics
INTERESTED? INTRIGUED? INSPIRED?
If you are interested in a collaborative partnership or see Indivumed as your next employer, please do not hesitate to get in touch. We look forward to hearing from you.